More reads
- King of generics pushes into biotech drugs. (Wall Street Journal)
- Drug company payments for consulting and speaking influence oncologists’ prescribing. (STAT Plus)
- Behind the failure of the first U.S. uterine transplant. (Washington Post)
- The challenges in bringing an anti-aging pill to market. (Forbes)
.png)
No hay comentarios:
Publicar un comentario